NASDAQ:NERV

Minerva Neurosciences Stock Forecast

etoro logo Buy NERV
*Your capital is at risk
$4.51
-0.110 (-2.38%)
At Close: Jun 12, 2026
AI Analysis AI Analysis of NERV AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add NERV to Watchlist?
Some Reasons Why To Add NERV:
  • +150.6% price growth over the last year
  • Lower volatility than the market (beta -0.17)
  • Strong return on equity of 359.8%
PDF

Minerva Neurosciences stock price down 2.38% on Friday
(Updated on Jun 12, 2026)

Sell candidate since May 06, 2026 Loss -27.61%

The Minerva Neurosciences stock price fell by -2.38% on the last day (Friday, 12th Jun 2026) from $4.62 to $4.51. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 7.95% from a day low at $4.40 to a day high of $4.75. The price has fallen in 7 of the last 10 days and is down by -8.15% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -17 thousand shares and in total, 83 thousand shares were bought and sold for approximately $373.87 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -28.67% during the next 3 months and, with a 90% probability hold a price between $2.65 and $4.26 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

NERV Signals & Forecast

There are mixed signals in the stock today. The Minerva Neurosciences stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.70 and $5.40. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 3.44%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Minerva Neurosciences stock

Minerva Neurosciences finds support from accumulated volume at $4.36 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.350 between high and low, or 7.95%. For the last week the stock has had daily average volatility of 7.75%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NERV) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Minerva Neurosciences to open at $4.55, and during the day (based on 14 day Average True Range), to move between $4.31 and $4.71, which gives a possible trading interval of +/-$0.394 (+/-9.13%) up or down from last closing price. If Minerva Neurosciences takes out the full calculated possible swing range there will be an estimated 9.13% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.36 (3.33%) than the resistance at $5.03 (11.53%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Minerva Neurosciences stock A Buy?

Minerva Neurosciences holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.199 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $4.55 ( 0.96%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

NERV Performance

Trading levels for NERV

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.90 8.72%
R2 4.77 5.76%
R1 4.69 3.93%
Price 4.51
S1 4.42 -2.00%
S2 4.34 -3.84%
S3 4.20 -6.80%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.55 23.06%
R2 5.42 20.18%
R1 5.03 11.53%
Price 4.51
S1 4.36 -3.33%
S2 0 -
S3 0 -

FAQ

What is the symbol for Minerva Neurosciences Stock and on which exchange is it traded?
The symbol for Minerva Neurosciences is NERV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Minerva Neurosciences Stock?
Minerva Neurosciences holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Minerva Neurosciences Stock?
Minerva Neurosciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Minerva Neurosciences Stock.

What's the current price of Minerva Neurosciences Stock?
As of the end of day on the Jun 12, 2026, the price of an Minerva Neurosciences (NERV) share was $4.51.

What is the 52-week high and low for Minerva Neurosciences Stock?
The 52-week high for Minerva Neurosciences Stock is $12.46 and the 52-week low is $1.57.

What is the market capitalization of Minerva Neurosciences Stock?
As of the Jun 12, 2026, the market capitalization of Minerva Neurosciences is 31.538M.

When is the next earnings date for Minerva Neurosciences?
The upcoming earnings date for Minerva Neurosciences is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT MINERVA NEUROSCIENCES
Minerva Neurosciences
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, ...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE